共 39 条
- [31] TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor VaccinationJOURNAL OF IMMUNOLOGY, 2009, 183 (06): : 3634 - 3641Pulko, VesnaLiu, XinKrco, Christopher J.Harris, Kimberley J.Frigola, XavierKwon, Eugene D.Dong, Haidong
- [32] Dendritic Cells Exposed to MVA-Based HIV-1 Vaccine Induce Highly Functional HIV-1-Specific CD8+ T Cell Responses in HIV-1-Infected IndividualsPLOS ONE, 2011, 6 (05):Climent, NuriaGuerra, SusanaGarcia, FelipeRovira, CristinaMiralles, LaiaElena Gomez, CarmenPique, NuriaGil, CristinaMaria Gatell, JoseEsteban, MarianoGallart, Teresa
- [33] A single-cell atlas of the effect of chemotherapeutics over intratumoral immune cells reveals that combining an alkylating agent and a vinca alkaloid can activate antigen presenting cells and increase tcf1+stem-like CD8+T-cells, thus improving anti-PD-1 efficacy in triple negative breast cancer and lymphoma.CANCER RESEARCH, 2021, 81 (13)Falvo, PaoloOrecchioni, StefaniaHillje, RomanRaveane, AlessandroMitola, GiuliaMancuso, PatriziaCamisaschi, ChiaraLuzi, LucillaPelicci, PierGiuseppeBertolini, Francesco
- [34] TLR-Stimulated CD34 Stem Cell-Derived Human Skin-Like and Monocyte-Derived Dendritic Cells Fail to Induce Th17 Polarization of Naive T Cells but Do Stimulate Th1 and Th17 Memory ResponsesJOURNAL OF IMMUNOLOGY, 2009, 183 (04): : 2242 - 2251Duraisingham, Sai SudaHornig, JuliaGotch, FrancesPatterson, Steven
- [35] ART1 tumor expression mediates immune resistance in non-small cell lung cancer by elimination of P2 x 7R+CD8 tissue resident memory T cells and conventional type I dendritic cellsCANCER RESEARCH, 2020, 80 (16)Wennerberg, ErikHung, ClareyValeta, AmandaMcGraw, TimothyDemaria, SandraStiles, Brendon
- [36] Self-assembling peptide for co-delivery of HIV-1 CD8+T cells epitope and Toll-like receptor 7/8 agonists R848 to induce maturation of monocyte derived dendritic cell and augment polyfunctional cytotoxic T lymphocyte (CTL) responseJOURNAL OF CONTROLLED RELEASE, 2016, 236 : 22 - 30Ding, YongLiu, JunLu, ShengIgweze, JusticeXu, WenKuang, DaZealey, ChrisLiu, DahengGregor, AlexBozorgzad, ArdalanZhang, LeiYue, ElizabethMujib, ShariqOstrowski, MarioChen, P.
- [37] In situ anti-tumor immunization using the tumor microenvironment reprograming with a TLR4-agonist induces strong CD4 and CD8 T cells responses, long-living T cell memory, and protection against 4T1 metastatic breast cancer in miceEUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 391 - 391Ushakova, E.Savchenko, M.Lebedeva, E.Pichugin, A.Ataullakhanov, R.
- [38] Mammaglobin B (SCGB2A1)-specific CD8+ cytotoxic T lymphocytes (CTL) are highly effective in killing autologous chemotherapy resistant ovarian cancer cells: Implications for SCGB2A1 dendritic cell-based therapeutic vaccinesGYNECOLOGIC ONCOLOGY, 2012, 125 : S34 - S34Roque, D.Bellone, S.Betti, M.Silasi, D.Ratner, E.Azodi, M.Schwartz, P.Rutherford, T.Pecorelli, S.Santin, A.
- [39] Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic VaccinesJOURNAL OF VIROLOGY, 2009, 83 (13) : 6779 - 6789Bellone, StefaniaEl-Sahwi, KarimCocco, EmilianoCasagrande, FrancescaCargnelutti, MarilisaPalmieri, MichelaBignotti, ElianaRomani, ChiaraSilasi, Dan-ArinAzodi, MasoudSchwartz, Peter E.Rutherford, Thomas J.Pecorelli, SergioSantin, Alessandro D.